UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2024
Commission File Number: 001-41089
Advanced Health Intelligence Ltd
(Translation of registrant’s name into English)
71-73 South Perth Esplanade, Unit 5
South Perth, WA 6151
Australia
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
Attached as Exhibit 99.1 to this Report on Form 6-K is a copy of the press
release of Advanced Health Intelligence Ltd, dated August 19, 2024: “AHI RECEIVES PRESTIGEOUS INNOVATION AWARD AT SOUTH-EAST ASIA’S
LARGEST TECHNOLOGY CONFERENCE”
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
ADVANCED HEALTH INTELLIGENCE LTD |
| |
|
|
| Date: August 19, 2024 |
By: |
/s/ Scott Montgomery |
| |
|
Name: |
Scott Montgomery |
| |
|
Title: |
Chief Executive Officer |
Exhibit 99.1
AHI RECEIVES PRESTIGEOUS INNOVATION AWARD
AT SOUTH-EAST ASIA’S LARGEST TECHNOLOGY CONFERENCE
Highlights
| · | | AHI receives Innovation award
at Techsauce Global Summit for its advanced health risk assessment technologies |
| · | | AHI was the only health tech
award recipient, selected from 300 attending exhibitors |
| · | | Techsauce Global Summit is South-East
Asia’s largest technology conference with over 20,000 delegates held in Bangkok, Thailand 7-9 August 2024 |
| · | | AHI attended Techsauce Global
Summit as part of a delegation of 18 technology companies arranged by the Australian Trade and Investment Commission |
Advanced Health Intelligence
Ltd (ASX/NASDAQ:AHI) (“AHI” or “the Company”) is pleased to announce that it has been named
winner of Techsauce’s Innovation Award at the Techsauce Global Summit, held from 7-9 August in Bangkok, Thailand. The Innovation
Award is part of a prestigious recognition program to celebrate groundbreaking achievements in technology,
entrepreneurship, and innovation.
AHI was selected from over 300
exhibitors involved in the Techsauce Global Summit 2024, based on criteria including originality,
technical excellence, positive impact on society and more. Nominations called for companies that have made significant
contributions to their respective fields through innovative solutions, products or services. AHI was the only health tech company
to receive one of the 11 prestigious awards issued in 2024.
AHI attended the Techsauce Global
Summit as part of a delegation of 18 technology companies invited by The Australian Trade and Investment Commission (Austrade). Austrade
is a statutory agency of the Australian Government and forms part of the Department of Foreign Affairs and Trade (DFAT) portfolio. Austrade
offers support services to help Australian businesses expand in overseas markets.
In addition to healthcare, the
delegation included Australian companies leveraging AI to offer technology solutions to multiple other industries including reg-tech,
software development, digital business.
Scott Montgomery, CEO, received
the award on behalf of AHI. Scott Montgomery comments:
“I’m truly proud
of our team’s work to enable AHI to be recognised as one of the leading health technology companies in Asia. AHI’s team has
developed something truly impactful to help economically scale better healthcare outcomes and we’re very grateful for that capability
to be recognised by South-East Asia’s largest technology stage. Techsauce was the perfect platform for us to meet Board and C-suite
level heads of industry of hospitals, telehealth and med-tech regulators so to be recognised as an innovation leader in front of this
level of leadership is tangibly valuable to the Company.”
“I want to express a deep
gratitude to the Austrade team for selecting AHI to attend and coordinating this mission to Thailand. Their ability to connect our innovations
to Thailand’s leading hospitals is the best facilitation I’ve experienced”.
Techsauce is the leading technology
business media and publication in Thailand. Its annual three-day summit features conference presentations, exhibits, workshops and networking,
and is attended by over 20,000 delegates and more than 300 exhibitors.
The Chairman and CEO of Advanced
Health Intelligence Ltd have approved this announcement.
Advanced
Health Intelligence Ltd.
ACN
602 111 115
Postal
Address: PO Box 190, South Perth WA 6951
Email:
investors@ahi.tech
Market release
19 August 2024
For more information, contact:
|
Scott Montgomery
Chief Executive Officer
Advanced Health Intelligence Ltd
E: admin@ahi.tech |
Laura Wilson
Marketing and PR
Advanced Health Intelligence Ltd
E: marketing@ahi.tech |
About Advanced Health Intelligence Ltd
AHI offers a cutting-edge, smart-phone-based health
risk identification solution that enables individuals to run their own comprehensive health assessments and risk stratification. Utilising
smartphone sensor technology, individuals can efficiently conduct a single scan or a series of scans to identify established risk markers
for various health conditions. The resulting data can then be shared with healthcare providers, insurers, employers, and government agencies,
facilitating timely triage and appropriate care pathway allocation.
AHI’s scientific research capability is dedicated to the development
of advanced data capture techniques, optimising data input signal quality and continuous enhancement and validation of AHI's solutions
through rigorous scientific processes.
Over the past decade, AHI has been at the forefront
of health-tech innovation, pioneering the use of smartphones in digital-first healthcare. Our journey began with the groundbreaking development
of the world's first on-device body dimensioning capability. Since then, we have continued to evolve and adapt our solutions to meet the
dynamic needs of health systems players, who are dedicated to delivering high-quality patient care and early detection of escalating health
conditions. AHI's patented technology has enabled us to push the boundaries of early detection through digital healthcare, offering a
suite of modular solutions that are transforming the industry and offering earlier intervention opportunities.
AHI has assembled a team of
experts in machine learning, artificial intelligence, biomathematical modelling and systems biology, computer vision, clinical expertise,
and medically trained data scientists to develop and deploy this cutting-edge risk assessment tool. This comprehensive solution encompasses:
| · | | Anthropometric and body composition analysis to identify obesity-related comorbidities, including
diabetes risk stratification. |
| · | | Predictive modelling of blood biomarkers, (including HbA1C, HDL-C, LDL-C), and 10-year cardiovascular
risk estimation. |
| · | | Facial blood analysis technology to assess vital signs non-invasively and provide risk stratification
for cardiovascular disease. |
| · | | Device-derived dermatological image analysis for identifying over 588 skin conditions across
134 categories, including melanoma detection. |
AHI has developed a biometrically
driven triage solution using only a smartphone. This solution enables the identification of health risks across populations and directs
individuals to appropriate care pathways for proactive health management. The technology provides cost-effective health screening access
to billions of smartphone users worldwide, empowering these individuals to take charge of their health journey and improving health outcomes
globally.
For more information, please visit: www.ahi.tech.
Advanced
Health Intelligence Ltd.
ACN
602 111 115
Postal
Address: PO Box 190, South Perth WA 6951
Email:
investors@ahi.tech
Advanced Health Intellig... (NASDAQ:AHI)
Historical Stock Chart
From Nov 2024 to Dec 2024
Advanced Health Intellig... (NASDAQ:AHI)
Historical Stock Chart
From Dec 2023 to Dec 2024
